Author: OurCrowd

[verse.io in Newswires] Verse.io welcomes Damien Swendsen as new SVP of Revenue

Jul 19, 2023 |

SAN DIEGO, CALIFORNIA, UNITED STATES, July 19, 2023/EINPresswire.com/ — Verse.io, the market leader in conversational AI for business texting and customer outreach, is pleased to announce the appointment of Damien Swendsen as its new Senior Vice President of Revenue. With over two decades of technology sales experience and a proven track record of success, Damien will play a pivotal role in driving Verse’s growth, expanding its customer base, establishing strategic partnerships, and strengthening the company’s brand presence. Read...

Read More

[Scopio in PR Newswire] Beckman Coulter connects Scopio Labs Digital Cell Morphology with Hematology Workcell extending automated workflow

Jul 19, 2023 |

ANAHEIM, Calif., July 19, 2023 /PRNewswire/ — Beckman Coulter, a global leader in clinical diagnostics, today announced it will debut its hematology analyzer and slidemaker stainer connected to Scopio Labs’ digital morphology platform for end-to-end digitization with artificial intelligence-assisted peripheral blood smear analysis at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo. The solution features the Beckman Coulter DxH 900 Workcell and DxH Slidemaker Stainer II connected with the Scopio X100HT digital morphology platform capable of continuous loading, scanning and analysis. Read more...

Read More

[Eko Health in PR Newswire] Astellas and Eko Health announce agreement to incorporate next generation Eko CORE 500™ Digital Stethoscope into Z1608, an innovative solution under development for heart failure patients built on Welldoc’s proven digital therapeutic platform

Jul 18, 2023 |

TOKYO, EMERYVILLE, Calif. and COLUMBIA, Md., July 18, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Eko Health Inc. (Co-Founder and CEO: Connor Landgraf, “Eko”) announced today that they have entered into a License & Supply Agreement for the global supply and license of Eko’s latest digital stethoscope, the CORE 500™, and a custom suite of Eko’s AI-powered cardiovascular disease detection software. Working collaboratively with Welldoc, Inc. (President, CEO: Kevin McRaith, “Welldoc”), Astellas intends to integrate Eko’s technology with Welldoc’s cardiometabolic digital therapeutic (DTx) capabilities to create a proprietary, non-invasive device-DTx solution for patients with heart failure, currently known as Z1608. Astellas intends to seek U.S. Food and Drug Administration (FDA) clearance for Z1608. Read...

Read More

[DailyPay in Restaurant Dive] Freebirds World Burrito continues to improve employee experience, partners with DailyPay

Jul 18, 2023 |

NEW YORK — Freebirds World Burrito, home of Texas’ No. 1 Burrito, has partnered with DailyPay– the leading provider of on-demand pay. As a best-in-class employer, Freebirds World Burrito continues to improve its employee benefits package in an effort to prioritize employee happiness, adding the financial wellness benefit of on-demand pay to its offerings. Through this partnership, Freebirds employees can access their earned wages immediately after completing a shift allowing them to save, spend, and invest their pay on their own schedules. Read...

Read More

[Captiv8 in Business Wire] Captiv8 partners with The Brandr Group to provide analytics, reporting and performance measurement for NIL group licensing campaigns

Jul 18, 2023 |

SAN FRANCISCO–(BUSINESS WIRE)–Captiv8 welcomes The Brandr Group (TBG) as their newest partner to the Captiv8 Collegiate family. Now approaching two years since NIL officially entered collegiate athletics, Captiv8 Collegiate continues to grow as it provides a platform solution, resources, consultation and opportunities for NIL service providers, universities and agencies.   Read...

Read More